MariMed Inc. (MRMD)
OTCMKTS: MRMD · Delayed Price · USD
0.310
-0.015 (-4.60%)
May 1, 2024, 2:19 PM EDT - Market open
MariMed Revenue
In the year 2023, MariMed had annual revenue of $148.60M with 10.89% growth. Revenue in the quarter ending December 31, 2023 was $38.90M with 8.57% year-over-year growth.
Revenue (ttm)
$148.60M
Revenue Growth
+10.89%
P/S Ratio
0.77
Revenue / Employee
$231,101
Employees
643
Market Cap
114.10M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 148.60M | 14.59M | 10.89% |
Dec 31, 2022 | 134.01M | 12.55M | 10.33% |
Dec 31, 2021 | 121.46M | 70.57M | 138.66% |
Dec 31, 2020 | 50.90M | 5.29M | 11.60% |
Dec 31, 2019 | 45.60M | 33.75M | 284.79% |
Dec 31, 2018 | 11.85M | 5.78M | 95.32% |
Dec 31, 2017 | 6.07M | 2.50M | 70.25% |
Dec 31, 2016 | 3.56M | 2.29M | 180.60% |
Dec 31, 2015 | 1.27M | 1.18M | 1,337.11% |
Dec 31, 2014 | 88.38K | 87.48K | 9,676.99% |
Dec 31, 2013 | 904.00 | 119.00 | 15.16% |
Dec 31, 2012 | 785.00 | -124.82K | -99.38% |
Dec 31, 2011 | 125.61K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
MRMD News
- 1 day ago - Statement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration's Decision To Recategorize Cannabis To Schedule III - GlobeNewsWire
- 18 days ago - 3 Marijuana Stocks To Add To Your Watchlist This Week - MarijuanaStocks
- 20 days ago - MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary - GlobeNewsWire
- 21 days ago - MariMed Partners with Iconic Boston Music Venues - GlobeNewsWire
- 22 days ago - MariMed Closes Acquisition of Second Maryland Dispensary - GlobeNewsWire
- 23 days ago - MariMed Announces First Quarter 2024 Earnings Date - GlobeNewsWire
- 7 weeks ago - A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, Illinois - GlobeNewsWire
- 2 months ago - MariMed Reports Fourth Quarter and Full Year 2023 Earnings - GlobeNewsWire